NPI: 1699066746 · YAZOO CITY, MS 39194 · Specialist · NPI assigned 04/25/2011
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP/CLO) |
| Parent Organization | BAPTIST MEMORIAL HEALTH CARE CORP. |
| NPI Enumeration Date | 04/25/2011 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,608 | $245K |
| 2019 | 9,824 | $438K |
| 2020 | 8,198 | $269K |
| 2021 | 8,317 | $248K |
| 2022 | 10,107 | $157K |
| 2023 | 27,281 | $313K |
| 2024 | 6,575 | $125K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15,283 | 12,394 | $1.28M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,094 | 4,932 | $369K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 558 | 464 | $56K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 254 | 230 | $32K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 311 | 267 | $31K |
| 36415 | Collection of venous blood by venipuncture | 4,561 | 3,804 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,092 | 2,436 | $6K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 144 | 129 | $6K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 435 | 389 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,901 | 2,286 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 117 | 107 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,169 | 1,146 | $1K |
| 0012A | 68 | 67 | $704.35 | |
| 0011A | 89 | 79 | $628.73 | |
| 3078F | 5,760 | 4,441 | $384.48 | |
| 3079F | 2,287 | 1,717 | $382.80 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 96 | 73 | $355.38 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 27 | 14 | $255.62 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 55 | 53 | $194.25 |
| 3077F | 3,433 | 2,577 | $193.16 | |
| 3008F | 8,547 | 6,508 | $170.64 | |
| 3080F | 1,100 | 810 | $169.72 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 110 | 85 | $165.49 |
| 3074F | 4,410 | 3,333 | $143.95 | |
| 90686 | 126 | 117 | $130.16 | |
| 0013A | 16 | 14 | $107.61 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 616 | 425 | $22.75 |
| 3075F | 1,515 | 1,165 | $20.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 338 | 250 | $6.72 |
| 1159F | 5,202 | 3,479 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 231 | 213 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 24 | 12 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 83 | 72 | $0.00 |
| 1160F | 2,920 | 1,995 | $0.00 | |
| 81025 | 114 | 82 | $0.00 | |
| 1125F | 819 | 572 | $0.00 | |
| 91301 | 78 | 71 | $0.00 | |
| 1126F | 879 | 610 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 29 | 17 | $0.00 |
| 90656 | 19 | 19 | $0.00 |